These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6774329)

  • 21. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
    Smith R; Donald RA; Espiner EA; Stronach SG; Edwards IA
    J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypogonadotropic hypogonadism].
    Marina S; Jiménez F
    Rev Iber Endocrinol; 1972; 19(113):439-47. PubMed ID: 5082836
    [No Abstract]   [Full Text] [Related]  

  • 23. [Data on the hematic conversion of testosterone into dihydrotestosterone in subjects with hypogonadism].
    Concolino G; Marocchi A; Sorcini G; Sciarra F
    Folia Endocrinol; 1973 Aug; 26(4):268-80. PubMed ID: 4801001
    [No Abstract]   [Full Text] [Related]  

  • 24. A possible role for reproductive hormones in newborn boys: progressive hypogonadism without the postnatal testosterone peak.
    Main KM; Schmidt IM; Skakkebaek NE
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4905-7. PubMed ID: 11134160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of undiagnosed testosterone deficiency in aging athletes: does exercise training influence the symptoms of male hypogonadism?
    Di Luigi L; Sgrò P; Fierro V; Bianchini S; Battistini G; Magini V; Jannini EA; Lenzi A
    J Sex Med; 2010 Jul; 7(7):2591-601. PubMed ID: 20141589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paternity in idiopathic hypothalamic hypogonadism during testosterone therapy in two unrelated patients.
    de Lange WE; Doorenbos H
    Neth J Med; 1990 Aug; 37(1-2):77-9. PubMed ID: 2120600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigations on male hypogonadism.
    Prunty FT; Davidson NM; Hutchinson JS; Reid DJ
    Proc R Soc Med; 1969 Jan; 62(1):27-31. PubMed ID: 5763461
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of primary hypogonadism in men by the transdermal administration of testosterone.
    Findlay JC; Place V; Snyder PJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):369-73. PubMed ID: 2493029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the relationship between spermatogenesis and urinary levels of follicle stimulating hormone and luteinizing hormone in oligospermic men.
    Christiansen P
    Acta Endocrinol (Copenh); 1975 Jan; 78(1):192-208. PubMed ID: 1172892
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of urinary excretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH) by medroxyprogesterone acetate.
    Rifkind AB; Kulin HE; Cargille CM; Rayford PC; Ross GT
    J Clin Endocrinol Metab; 1969 Apr; 29(4):506-13. PubMed ID: 4888564
    [No Abstract]   [Full Text] [Related]  

  • 32. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of pulsatile gonadotropin secretion by testosterone in man.
    Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1984 Apr; 58(4):609-14. PubMed ID: 6421864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of urinary gonadotrophins.
    Girard J; Hadziselimovic F
    Eur J Pediatr; 1987; 146 Suppl 2():S18-20. PubMed ID: 2891512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and Treatment of Male Hypogonadism.
    Sargis RM; Davis AM
    JAMA; 2018 Apr; 319(13):1375-1376. PubMed ID: 29550857
    [No Abstract]   [Full Text] [Related]  

  • 36. Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism.
    Cisternino M; Manzoni SM; Coslovich E; Autelli M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():885-90. PubMed ID: 10091162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of estrogen in the modulation of pituitary sensitivity of LRF (luteinizing hormone-releasing factor) in men.
    Wang CF; Lasley BL; Yen SS
    J Clin Endocrinol Metab; 1975 Jul; 41(1):41-3. PubMed ID: 1097463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of prolactin and TSH response to TRH in hypotonadotropic hypogonadism.
    Yamaji T; Shimamoto K; Kosaka K; Isurugi K
    J Clin Endocrinol Metab; 1977 Aug; 45(2):319-23. PubMed ID: 407241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acquired hypogonadotropic hypogonadism in a man with primary empty sella turcica].
    González-González A; Madrid Muñiz Mdel C; Cordero Lozano MÁ; Recio Córdova JM
    Endocrinol Nutr; 2010 Oct; 57(8):397-9. PubMed ID: 20541482
    [No Abstract]   [Full Text] [Related]  

  • 40. Sex steroids and sexual desire in a man with a novel mutation of aromatase gene and hypogonadism.
    Carani C; Granata AR; Rochira V; Caffagni G; Aranda C; Antunez P; Maffei LE
    Psychoneuroendocrinology; 2005 Jun; 30(5):413-7. PubMed ID: 15721053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.